SCHEMBL6590757

SCHEMBL6590757

CC(C)(C)OC(=O)NC1CCn2c(cc3ccccc32)C1

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KCNA3 P22001 1/20 0.50
CKS1B P61024 1/20 0.47
SKP1 P63208 1/20 0.47
SKP2 Q13309 1/20 0.47
CTSK P43235 2/20 0.45
SIGMAR1 Q99720 1/20 0.45
OPRM1 P35372 1/20 0.44
OPRD1 P41143 1/20 0.44
OPRK1 P41145 1/20 0.44
OGFRL1 Q5TC84 1/20 0.44
KMT2A Q03164 1/20 0.44
L3MBTL1 Q9Y468 1/20 0.44
DRD2 P14416 2/20 0.43
KDM1A O60341 1/20 0.43
MAOB P27338 1/20 0.43
NAMPT P43490 1/20 0.43
EPHX2 P34913 1/20 0.43
USP14 P54578 1/20 0.42
PDE10A Q9Y233 1/20 0.42
PIM1 P11309 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8640229 0.83 HTR2A (0.43) KCNA3CTSKSIGMAR1CNR1CNR2
SCHEMBL8653934 0.83 KMT2A (0.46) KCNA3CKS1BSKP1SKP2CTSK
SCHEMBL8653071 0.81 ACACB (0.50) CKS1BSKP1SKP2DRD2
SCHEMBL16447392 0.74 USP30 (0.41) KCNA3CTSKKMT2AL3MBTL1DRD2
SCHEMBL7661329 0.73 USP14 (0.50) KCNA3CKS1BSKP1SKP2CTSK
SCHEMBL19284706 0.72 CKS1B (0.57) KCNA3CKS1BSKP1SKP2OPRM1
SCHEMBL8327513 0.72 HTR2A (0.34) CKS1BSKP1SKP2SIGMAR1KMT2A
SCHEMBL8325934 0.72 HTR2A (0.34) CKS1BSKP1SKP2SIGMAR1KMT2A
SCHEMBL8346364 0.71 NAMPT (0.62) CKS1BSKP1SKP2KMT2ANAMPT
SCHEMBL16003610 0.71 CKS1B (0.58) KCNA3CKS1BSKP1SKP2CTSK

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1183252-B1 PHARMACEUTICALLY ACTIVE COMPOUNDS ASTRAZENECA AB (SE) 2004-02-18 EP disclosed
US-6492406-B1 PROTEIN KINASE C INHIBITORS; ANTIINFLAMMATORY AND IMMUNO-SUPPRESSIVE AGENTS ASTRAZENECA AB (SE) 2002-12-10 US disclosed
US-5721245-A ANTIINFLAMMATORY AGENTS, RESPIRATORY SYSTEM DISORDERS, CARDIOVASCULAR DISORDERS HOFFMANN-LA ROCHE INC. (US) 1998-02-24 US disclosed
EP-0384349-B1 Substituted pyrroles HOFFMANN LA ROCHE (CH) 1994-04-27 EP disclosed
EP-0384349-A1 Substituted pyrroles F. HOFFMANN-LA ROCHE AG (CH) 1990-08-29 EP disclosed